University of California Los Angeles-医療機器分野:企業M&A・提携分析

◆英語タイトル:University of California Los Angeles - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011520
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of California Los Angeles (UCLA) a subsidiary of University of California is an educational service provider that offers undergraduate education, graduate, professional education and continuing education. The university’s services include support services, campus services, graduate degree and undergraduate degree program and also provides research services in libraries, museums, film, music archives, art galleries, horizon-broadening, humanity-serving of California. UCLA operates through its departments including anthropology, archaeology, applied linguistics, architecture and urban design, bio-engineering, bio-medical research, dentistry and digital humanities. The university also conducts variety of programs for students in community operations. UCLA is headquartered in Los Angeles, California, the US.

University of California Los Angeles – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of California Los Angeles, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
University of California Los Angeles, Medical Equipment Deals By Type, 2011 to YTD 2017 7
University of California Los Angeles, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
University of California Los Angeles, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
University of California Los Angeles, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
University of California Los Angeles, Medical Equipment, Deal Details 12
Partnerships 12
Zymo Research Enters into Licensing Agreement with UCLA for Epigenetic Aging Clock Technology 12
Bone Biologics Enters into Option Agreement with UCLA 13
ImaginAb Enters into Technology Licensing Agreement with University of California, Los Angeles 14
NSVascular Enters Into Licensing Agreement With University of California 15
ImaginAb Enters Into Technology Licensing Agreement With University of California, Los Angeles 16
EpicGenetics Enters into Agreement with University of California Los Angeles and University of Illinois College of Medicine at Chicago 17
OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 18
University of California and UCLA Department of Pathology form Joint Venture with Centre Testing International 19
Fibrocell Science Enters Into Research Agreement With University Of California 20
Fibrocell Science Enters into Licensing Agreement with University of California to Advance the Development of Personalized Cell Therapies 21
Fibrocell Science Enters Into Licensing Agreement With University of California 22
Merganser Biotech Enters Into Option Licensing Agreement With UCLA 23
University of California Los Angeles – Key Competitors 24
University of California Los Angeles – Key Employees 25
University of California Los Angeles – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 28
Recent Developments 29
Government and Public Interest 29
Dec 13, 2016: Experimental implant shows promise for restoring voluntary movement after spinal cord injury 29
Product News 31
Dec 11, 2017: Neuroscientists show deep brain waves occur more often during navigation and memory formation 31
Dec 05, 2017: Doctors develop new way to use MRI to predict pregnancy complications 32
Oct 03, 2017: New method to measure cell stiffness could lead to improved cancer treatments 33
May 22, 2017: Scientists develop test to identify best treatment for gonorrhea 34
May 10, 2017: Battery-free implantable medical device draws energy directly from human body 35
Aug 26, 2016: UCLA researchers develop method to speed up detection of infectious diseases, cancer 36
Aug 24, 2016: UCLA scientists use ultrasound to jump-start a man’s brain after coma 38
Aug 23, 2016: MRI scans may be useful in diagnosing chronic traumatic encephalopathy, UCLA study shows 39
Aug 04, 2016: A simple treatment for a Common Breathing Problem Among Premature Infants 40
Jun 09, 2016: Scientists discover biomarkers that could give cancer patients better survival estimatesl 42
Mar 24, 2016: NantWorks and UCLA Researchers Develop Method to Achieve High Accuracy Classification of Cancer Cells in Native Form 43
Feb 10, 2016: Remote telemonitoring does not reduce hospital readmissions for heart failure patients 44
Feb 09, 2016: Computational tools could change the way sleep apnea is treated 45
Jan 28, 2016: Electric Patch Holds Promise for Treating PTSD 46
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
University of California Los Angeles, Medical Equipment, Key Facts 2
University of California Los Angeles, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
University of California Los Angeles, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
University of California Los Angeles, Medical Equipment Deals By Type, 2011 to YTD 2017 7
University of California Los Angeles, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
University of California Los Angeles, Deals By Market, 2011 to YTD 2017 9
University of California Los Angeles, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Zymo Research Enters into Licensing Agreement with UCLA for Epigenetic Aging Clock Technology 12
Bone Biologics Enters into Option Agreement with UCLA 13
ImaginAb Enters into Technology Licensing Agreement with University of California, Los Angeles 14
NSVascular Enters Into Licensing Agreement With University of California 15
ImaginAb Enters Into Technology Licensing Agreement With University of California, Los Angeles 16
EpicGenetics Enters into Agreement with University of California Los Angeles and University of Illinois College of Medicine at Chicago 17
OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 18
University of California and UCLA Department of Pathology form Joint Venture with Centre Testing International 19
Fibrocell Science Enters Into Research Agreement With University Of California 20
Fibrocell Science Enters into Licensing Agreement with University of California to Advance the Development of Personalized Cell Therapies 21
Fibrocell Science Enters Into Licensing Agreement With University of California 22
Merganser Biotech Enters Into Option Licensing Agreement With UCLA 23
University of California Los Angeles, Key Competitors 24
University of California Los Angeles, Key Employees 25
University of California Los Angeles, Subsidiaries 26
University of California Los Angeles, Joint Venture 28

★海外企業調査レポート[University of California Los Angeles-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ascena Retail Group, Inc.:企業の戦略・SWOT・財務情報
    Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ascena Retail Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Seelos Therapeutics, Inc. (SEEL):企業の財務・戦略的SWOT分析
    Seelos Therapeutics, Inc. (SEEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bisnode AB:企業のM&A・事業提携・投資動向
    Bisnode AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bisnode AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Medical Developments International Ltd (MVP):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company provides products such as penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products whic …
  • Magnis Resources Limited (MNS):企業の財務・戦略的SWOT分析
    Magnis Resources Limited (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • PriceSmart Inc (PSMT):企業の財務・戦略的SWOT分析
    PriceSmart Inc (PSMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fossil Group, Inc.:企業の戦略・SWOT・財務情報
    Fossil Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fossil Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Halt Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Halt Medical Inc (Halt Medical) is a healthcare service center that develops, manufactures and commercializes medical treatment for women with symptomatic uterine fibroids. The center offers Acessa System, a minimally invasive laparoscopic outpatient procedure to treat uterine fibroids. It o …
  • Laboratoire HRA Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoire HRA Pharma (HRA Pharma) is a healthcare products provider that offers women’s health and endocrinology products. The company offers a wide range of women’s health products which include emergency contraception, uterine fibroids, regular contraception and genital herp products amo …
  • TTK Prestige Limited:企業の戦略・SWOT・財務分析
    TTK Prestige Limited - Strategy, SWOT and Corporate Finance Report Summary TTK Prestige Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Korea Petrochemical Ind. Co Ltd (006650):企業の財務・戦略的SWOT分析
    Summary Korea Petrochemical Ind. Co Ltd (KPICL) is a chemical company that manufactures and markets petrochemical products. The company provides products such as olefins, aromatics, polypropylene, EO and EG, PP and HDPE. It provides olefins products such as ethylene, propylene, butene, butane, isobu …
  • Black Knight Financial Services, Inc. (BKFS):企業の財務・戦略的SWOT分析
    Black Knight Financial Services, Inc. (BKFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Sims Metal Management Limited:戦略・SWOT・企業財務分析
    Sims Metal Management Limited - Strategy, SWOT and Corporate Finance Report Summary Sims Metal Management Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • City Utilities of Springfield:企業の戦略的SWOT分析
    City Utilities of Springfield - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • GATX Corp (GATX):企業の財務・戦略的SWOT分析
    GATX Corp (GATX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kilitch Drugs India Ltd (KILITCH):製薬・医療:M&Aディール及び事業提携情報
    Summary Kilitch Drugs India Ltd (Kilitch) is a pharmaceutical company that manufactures and markets antibacterial parenteral formulations and other pharmaceutical products. The company offers products such as parenterals and nasal products, oral, effervesscent, nutritional products, medical device, …
  • Kinder Morgan, Inc.:企業の戦略・SWOT・財務情報
    Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sensile Medical AG:医療機器:M&Aディール及び事業提携情報
    Summary Sensile Medical AG (Sensile) is a medical device company that develops and produces key technologies for liquid drug delivery devices. The company develops products in the areas of micro insulin delivery and glucose monitoring systems. Its pipeline products comprise sensepatch and senseflex. …
  • Norsk Hydro ASA:企業の戦略・SWOT・財務分析
    Norsk Hydro ASA - Strategy, SWOT and Corporate Finance Report Summary Norsk Hydro ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析
    Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆